Neuroprotective effects of citicoline in in vitro models of retinal neurodegeneration

International Journal of Molecular Sciences

Volumn 15, Issue 4, 2014, Pages 6286-6297

  Matteucci, Andrea ^a   Varano, Monica ^b   Gaddini, Lucia ^a   Mallozzi, Cinzia ^a   Villa, Marika ^b   Pricci, Flavia ^a   Malchiodi Albedi, Fiorella ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

Apoptosis; Citicoline; Diabetic retinopathy; Excitotoxicity; Glaucoma; Neuroprotection; Primary retinal cultures

Indexed keywords

CASPASE 3; CITICOLINE; SYNAPTOPHYSIN; GLUCOSE; GLUTAMIC ACID; NEUROPROTECTIVE AGENT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL SURVIVAL; CONTROLLED STUDY; ELECTROPHORESIS; EMBRYO; EXCITOTOXICITY; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MORPHOMETRICS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; RAT; RETINA DISEASE; RETINAL NEURODEGENERATION; SYNAPSE; WESTERN BLOTTING; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; RETINA; TOXICITY;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CYTIDINE DIPHOSPHATE CHOLINE; GLUCOSE; GLUTAMIC ACID; MODELS, BIOLOGICAL; NEUROPROTECTIVE AGENTS; RATS; RETINA;

EID: 84898656978     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15046286     Document Type: Article

References (35)

1. Diederich, K.; Frauenknecht, K.; Minnerup, J.; Schneider, B.K.; Schmidt, A.; Altach, E.; Eggert, V.; Sommer, C.J.; Schäbitz, W.R. Citicoline enhances neuroregenerative processes after experimental stroke in rats. Stroke 2012, 43, 1931-1940.
2. Putignano, S.; Gareri, P.; Castagna, A.; Cerqua, G.; Cervera, P.; Cotroneo, A.M.; Fiorillo, F.; Grella, R.; Lacava, R.; Maddonni, A., et al. Retrospective and observational study to assess the efficacy of citicoline in elderly patients suffering from stupor related to complex geriatric syndrome. Clin. Interv. Aging 2012, 7, 113-118.
3. Cotroneo, A.M.; Castagna, A.; Putignano, S.; Lacava, R.; Fantò, F.; Monteleone, F.; Rocca, F.; Malara, A.; Gareri, P. Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study. Clin. Interv. Aging 2013, 8, 131-137.
4. Parisi, V.; Coppola, G.; Centofanti, M.; Oddone, F.; Angrisani, A.M.; Ziccardi, L.; Ricci, B.; Quaranta, L.; Manni, G. Evidence of the neuroprotective role of citicoline in glaucoma patients. Prog. Brain Res. 2008, 173, 541-554.
5. Parisi, V.; Manni, G.; Colacino, G.; Bucci, M.G. Cytidine-5'-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma. Ophthalmology 1999, 106, 1126-1134.
6. Rejdak, R.; Toczolowski, J.; Kurkowski, J.; Kaminski, M.L.; Rejdak, K.; Stelmasiak, Z.; Grieb, P. Oral citicoline treatment improves visual pathway function in glaucoma. Med. Sci. Monit. 2003, 9, 24-28.
7. Ottobelli, L.; Manni, G.L.; Centofanti, M.; Iester, M.; Allevena, F.; Rossetti, L. Citicoline oral solution in glaucoma: Is there a role in slowing disease progression? Ophthalmologica 2013, 229, 219-226.
8. Oshitari, T.; Yoshida-Hata, N.; Yamamoto, S. Effect of neurotrophic factors on neuronal apoptosis and neurite regeneration in cultured rat retinas exposed to high glucose. Brain Res. 2010, 1346, 43-51.
9. Mir, C.; Clotet, J.; Aledo, R.; Durany, N.; Argemi, J.; Lozano, R.; Cervos-Navarro, J.; Casals, N. CDP-choline prevents glutamate-mediated cell death in cerebellar granule neurons. J. Mol. Neurosci. 2003, 20, 53-60.
10. Matyja, E.; Taraszewska, A.; Nagańska, E.; Grieb, P.; Lowska, J. CDP-cholineprotects motor neurons against apoptotic changes in a model of chronic glutamate excitotoxicity in vitro. Folia Neuropathol. 2008, 46, 139-148.
11. Choi, D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1, 623-634.
12. Almasieh, M.; Wilson, A.M.; Morquette, B.; Cueva Vargas, J.L.; di Polo, A. The molecular basis of retinal ganglion cell death in glaucoma. Prog. Retin. Eye Res. 2012, 31, 152-181
13. Han, Y.S.; Chung, I.Y.; Park, J.M.; Yu, J.M. Neuroprotective effect of citicoline on retinal cell damage induced by kainic acid in rats. Korean J. Ophthalmol. 2005, 19, 219-226.
14. Baltmr, A.; Duggan, J.; Nizari, S.; Salt, T.E.; Cordeiro, M.F. Neuroprotection in glaucoma-Is there a future role? Exp. Eye Res. 2010, 91, 554-566.
15. Antonetti, D.A.; Barber, A.J.; Bronson, S.K.; Freeman, W.M.; Gardner, T.W.; Jefferson, L.S.; Kester, M.; Kimball, S.R.; Krady, J.K.; LaNoue, K.F., et al. Diabetic retinopathy: Seeing beyond glucose-induced microvascular disease. Diabetes 2006, 55, 2401-2411.
16. Lieth, E.; Gardner, T.W.; Barber, A.J.; Antonetti, D.A.; Penn State Retina Research Group. Retinal neurodegeneration: Early pathology in diabetes. Clin. Exp. Ophthalmol. 2000, 28, 3-8.
17. Parisi, V.; Uccioli, L. Visual electrophysiological responses in persons with type 1 diabetes. Diabetes Metab. Res. Rev. 2001, 17, 12-18.
18. Hernández, C.; Simó, R. Neuroprotection in diabetic retinopathy. Curr. Diabetes Rep. 2012, 12, 329-337.
19. Ola, M.S.; Nawaz, M.I.; Khan, H.A.; Alhomida, A.S. Neurodegeneration and neuroprotection in diabetic retinopathy. Int. J. Mol. Sci. 2013, 14, 2559-2572.
20. VanGuilder, H.D.; Brucklacher, R.M.; Patel, K.; Ellis, R.W.; Freeman, W.M.; Barber, A.J. Diabetes downregulates presynaptic proteins and reduces basal synapsin I phosphorylation in rat retina. Eur. J. Neurosci. 2008, 28, 1-11.
21. Santiago, A.R.; Rosa, S.C.; Santos, P.F.; Cristóvão, A.J.; Barber, A.J.; Ambrósio, A.F. Elevated glucose changes the expression of ionotropic glutamate receptor subunits and impairs calcium homeostasis in retinal neural cells. Investig. Ophthalmol. Vis. Sci. 2006, 47, 4130-4137.
22. Stem, M.S.; Gardner, T.W. Neurodegeneration in the pathogenesis of diabeticretinopathy: Molecular mechanisms and therapeutic implications. Curr. Med. Chem. 2013, 20, 3241-3250.
23. Adibhatla, R.M.; Hatcher, J.F.; Dempsey, R.J. Citicoline: Neuroprotective mechanisms in cerebral ischemia. J. Neurochem. 2002, 80, 12-23.
24. Xie, B.; Jiao, Q.; Cheng, Y.; Zhong, Y.; Shen, X. Effect of pigment epithelium-derived factor on glutamate uptake in retinal Muller cells under high-glucose conditions. Investig. Ophthalmol. Vis. Sci. 2012, 53, 1023-1032.
25. Malchiodi-Albedi, F.; Feher, J.; Caiazza, S.; Formisano, G.; Perilli, R.; Falchi, M.; Petrucci, T.C.; Scorcia, G.; Tombran-Tink, J. PEDF (pigment epithelium-derived factor) promotes increase and maturation of pigment granules in pigment epithelial cells in neonatal albino rat retinal cultures. Int. J. Dev. Neurosci. 1998, 1, 423-432.
26. Matteucci, A.; Cammarota, R.; Paradisi, S.; Varano, M.; Balduzzi, M.; Leo, L.; Bellenchi, G.C.; de Nuccio, C.; Carnovale-Scalzo, G.; Scorcia, G., et al. Curcumin protects against NMDA-induced toxicity: A possible role for NR2A subunit. Investig. Ophthalmol. Vis. Sci. 2011, 52, 1070-1077.
27. Malchiodi-Albedi, F.; Paradisi, S.; di Nottia, M.; Simone, D.; Travaglione, S.; Falzano, L.; Guidotti, M.; Frank, C.; Cutarelli, A.; Fabbri, A., et al. CNF1 improves astrocytic ability to support neuronal growth and differentiation in vitro. PLoS One 2012, 7, e34115.
28. Gaddini, L.; Villa, M.; Matteucci, A.; Mallozzi, C.; Petrucci, T.C.; di Stasi, A.M.; Leo, L.; Malchiodi-Albedi, F.; Pricci, F. Early effects of high glucose in retinal tissue cultures Renin-Angiotensin system-dependent and -independent signaling. Neurobiol. Dis. 2009, 35, 278-285
29. Hurtado, O.; Hernandez-Jimenez, M.; Zarruk, J.G.; Cuartero, M.I.; Ballesteros, I.; Camarero, G.; Moraga, A.; Pradillo, J.M.; Moro, M.A.; Lizasoain, I. Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke. J. Neurochem. 2013, 26, 819-826.
30. Hurtado, O.; Lizasoain, I.; Moro, M.A. Neuroprotection and recovery: Recent data at the bench on citicoline. Stroke 2011, 42, S33-S35.
31. Hurtado, O.; Pradillo, J.M.; Fernandez-Lopez, D.; Morales, J.R.; Sobrino, T.; Castillo, J.; Alborch, E.; Moro, M.A.; Lizasoain, I. Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke. Neurobiol. Dis. 2008, 29, 123-131.
32. Kitada, M.; Kume, S.; Kanasaki, K.; Takeda-Watanabe, A.; Koya, D. Sirtuins as possible drug targets in type 2 diabetes. Curr. Drug Targets 2013, 14, 622-636.
33. Saver, J.L. Citicoline: Update on a promising and widely available agent for neuroprotection and neurorepair. Rev. Neurol. Dis. 2008, 5, 167-177.
34. Secades, J.J.; Lorenzo, J.L. Citicoline: Pharmacological and clinical review, 2006 update. Methods Find Exp. Clin. Pharmacol. 2006, 28, 1-56.
35. Grieb, P. Neuroprotective properties of citicoline: Facts, doubts and unresolved issues. CNS Drugs 2014, 28, 185-193.